What is double sequential defibrillator
Reading File
Searching PubMed
double sequential defibrillation refractory ventricular fibrillation
Finding Sources
Reading Article
Reading Article
Reading File
Reading File
Reading File
I now have enough content to give a thorough answer. Let me compile everything.
Double Sequential Defibrillation (DSED)
Definition
Double sequential defibrillation (also called dual sequential defibrillation or DSED) is a technique that uses two sets of manual defibrillators to deliver two high-energy shocks either simultaneously or in rapid succession, aimed at patients with refractory ventricular fibrillation (VF) who have not responded to multiple standard shocks and antiarrhythmic drugs.
- Tintinalli's Emergency Medicine, p. 3887
- Braunwald's Heart Disease, p. 670
Why Is It Used?
It is reserved for shock-refractory VF, loosely defined as VF that persists after 3 or more attempts at standard defibrillation (or 3+ ICD shocks within 24 hours). Standard defibrillation uses a single vector to depolarize the myocardium; some VF persists because areas of myocardium remain in a relative refractory state outside the shock vector.
Proposed Mechanism
Two main theories exist:
- Increased energy delivery - Two defibrillators fire together, effectively doubling the energy delivered to the myocardium.
- Reduced VF threshold via dual vector - Two different shock pathways (vectors) depolarize a larger total mass of myocardium, overriding the relative refractory period in tissue that a single vector misses.
Tintinalli's, p. 4199
How It Is Performed
- The first set of pads is placed in the standard anterior-lateral (apex-sternum) position.
- A second set of pads is placed in the anterior-posterior position.
- Both defibrillators are charged to maximal settings (typically 360 J on biphasic, or whatever maximal output is available).
- Both shocks are delivered simultaneously (or within milliseconds of each other), requiring two operators to coordinate.
- This is attempted after standard CPR cycles, multiple escalating shocks, and administration of epinephrine and amiodarone/lidocaine have all failed.
Tintinalli's, p. 4199
DSED vs. Vector-Change Defibrillation (VCD)
A related but different technique is vector-change defibrillation: using a single defibrillator but switching the pad positions (e.g., from anterior-lateral to anterior-posterior) between shock attempts. Both DSED and VCD attempt to overcome refractory VF through alternative shock vectors.
Key Clinical Evidence
The DOSE-VF Trial (NEJM 2022; Cheskes et al.) was the landmark cluster RCT that tested both DSED and VCD against standard defibrillation in out-of-hospital cardiac arrest. It showed that:
- DSED was associated with significantly higher rates of survival to hospital discharge and good neurologic outcome compared to standard defibrillation.
- VCD also showed benefit, but DSED had the strongest signal.
Recent systematic reviews (2023-2024) present a more cautious picture:
| Study | Findings |
|---|---|
| Abuelazm et al., 2023 (network meta-analysis, n=1,632) | DSED was NOT significantly better than standard defibrillation for survival, neurologic outcome, or ROSC across pooled studies (PMID 37482919) |
| Yu et al., 2024 (meta-analysis, n=1,360) | The RCT (DOSE-VF) showed benefit for DSED, but pooled cohort studies did not. Simultaneous double defibrillation was actually associated with lower ROSC rates (RR 0.65). Concluded further large RCTs are needed. (PMID 39127020) |
Important Safety Note
- Manufacturer concerns: Simultaneous firing from two defibrillators can cause electrical damage to the devices themselves.
- The 2020 AHA/CPR guidelines note that DSED "has not been shown to improve outcomes" and it is not a standard first-line recommendation.
- Despite the promising DOSE-VF RCT signal, its routine use remains debated and is generally considered only after all standard measures have failed.
Morgan & Mikhail's Clinical Anesthesiology, p. 2000-2005
Summary
| Feature | Detail |
|---|---|
| Indication | Refractory VF after ≥3 failed standard shocks + drugs |
| Mechanism | Dual vector / doubled energy, lowers VF threshold |
| Technique | 2 defibrillators, 4 pads (ant-lat + ant-post), maximal simultaneous charge |
| Best evidence | DOSE-VF RCT (benefit), but pooled meta-analyses inconclusive |
| Guideline status | Not standard; may be considered when all else fails |
| Risk | Potential device damage; rescuer safety requires care |
This is a shared conversation. Sign in to Orris to start your own chat.